当前位置:
X-MOL 学术
›
Pharmacol. Rev.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction to "Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution".
Pharmacological Reviews ( IF 21.1 ) Pub Date : 2020-07-01 , DOI: 10.1124/pr.119.018440err
中文翻译:
对“针对Janus激酶和转录信号转导和转录激活因子3治疗炎症,纤维化和癌症:原理,进展和注意事项”的更正。
更新日期:2020-06-24
Pharmacological Reviews ( IF 21.1 ) Pub Date : 2020-07-01 , DOI: 10.1124/pr.119.018440err
中文翻译:
对“针对Janus激酶和转录信号转导和转录激活因子3治疗炎症,纤维化和癌症:原理,进展和注意事项”的更正。